Global Tensions Squeeze Indian Pharma: Rising Raw Material Costs a Growing Concern
Global Turmoil Squeezes India's Pharma: Drugmakers Plead for Input Price Caps
Ajay Piramal: India's Pharma Future Shines Bright, Driven by Talent and Cost Efficiency
India's Healthcare Boom: A Tale of Two Markets
Wockhardt's Game-Changer: India's First Homegrown NCE Accepted by USFDA – A New Dawn?